Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse Avatars.
Journal: Cancers
Published: April 12, 2026
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy.
Journal: BJU international
Published: September 11, 2025
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer.
Journal: European urology oncology
Published: October 09, 2023
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
Journal: Journal of the National Cancer Institute
Published: September 29, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].
Journal: European urology focus
Published: August 28, 2023
Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
Journal: Nature reviews. Urology
Published: May 22, 2023
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Journal: Urologic oncology
Published: May 04, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer.
Journal: Urologic oncology
Published: March 05, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
Journal: European urology focus
Published: February 09, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 04, 2023
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
Journal: The Journal of urology
Published: January 19, 2023
Last Updated: 09/26/2026